AGLE - Aeglea BioTherapeutics GAAP EPS of -$0.27 beats by $0.04 revenue of $0.63M misses by $0.08M
- Aeglea BioTherapeutics press release ( NASDAQ: AGLE ): Q2 GAAP EPS of -$0.27 (vs. -0.10 Y/Y) beats by $0.04 .
- Revenue of $0.63M (-95.4% Y/Y) misses by $0.08M .
- Shares +5.07% PM.
For further details see:
Aeglea BioTherapeutics GAAP EPS of -$0.27 beats by $0.04, revenue of $0.63M misses by $0.08M